The Patent Finder

RPG Life Sciences Limited

Also on record
Records under this name other than patents RPG Life Sciences Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to RPG Life Sciences Limited

PatentTitleStatus Expires Confidence
US 9,428,461Process for the preparation of a benzazepine derivative
Lapsed on the fee record
Ended Aug 30, 2020 · From the USPTO record
Lapsed on the fee recordEnded Aug 30, 2020From the USPTO record
US 8,063,217Process for preparation of methyl-(+)-(S)-alpha-(2-chlorophenyl)-6, 7-dihydrothieno[3,2-C]pyridine-5(4H) -acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
Lapsed on the fee record
Ended Nov 22, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 22, 2019From the USPTO record
US 6,897,308Process for the preparation of anti-psychotic 3-[2-[-4-(6-fluoro-1,2-benziosoxazol-3-yl)-1-piperidinyl] ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Lapsed on the fee record
Ended May 24, 2017 · From the USPTO record
Lapsed on the fee recordEnded May 24, 2017From the USPTO record
US 6,639,072Process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
Lapsed on the fee record
Ended Oct 28, 2015 · From the USPTO record
Lapsed on the fee recordEnded Oct 28, 2015From the USPTO record
US 7,056,530Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
Lapsed on the fee record
Ended Jun 6, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2014From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited